Navamedic ASA: Recommended cash offer to acquire Sensidose for approximately SEK 75 million

Oslo, 29 March 2023 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and provider of high-quality products to hospitals and pharmacies, has today submitted a cash offer to acquire all shares in Sensidose AB (“Sensidose”) for approximately SEK 75 million (the "Offer"). The Offer is recommended by the independent bid committee of Sensidose. The Sensidose shares are currently listed on...

Taggar: navamedic, recommended, offer